Jingfeng Pharmaceutical(SZ:000908) Zheng Quan Zhi Xing·2025-06-10 11:49Core Viewpoint - Hunan Jingfeng Pharmaceutical Co., Ltd. is involved in a lawsuit regarding a contractual dispute related to an investment agreement, which may impact its financial performance in the future [1][5]. Group 1: Lawsuit Details - The lawsuit was initiated by Hunan Jingfeng Pharmaceutical against defendants Anquan, Xiao Kun, and Azhua Hui concerning a breach of contract related to an investment agreement [1][2]. - The investment agreement involved an investment of 261 million yuan into Yunnan Jichang Geng Pharmaceutical Co., Ltd., with a valuation of 154.21 million yuan based on an estimated net profit multiple [2][3]. - The defendants failed to fulfill their capital contribution obligations, and the company claims to have suffered losses due to the defendants' misrepresentation of financial performance [3][4]. Group 2: Financial Implications - The company estimates a loss of at least 76.98 million yuan due to the alleged misrepresentation and breach of contract by the defendants [4][5]. - The impact of the lawsuit on the company's current and future profits remains uncertain as the case has not yet been heard in court [5].